Alfonsus J M van den Eertwegh

6PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Recommender systemsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2025
Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?

Bernies van der Hiel, Wouter V Vogel, Alfons J M van den Eertwegh

|Jul 18, 2024
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.

Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia

|Jul 20, 2022
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation.

Kim M van Pul, Jessica C L Notohardjo, Marieke F Fransen

|Jun 23, 2022
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier

|Mar 29, 2019
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Bas D Koster, Saskia J A M Santegoets, Jorien Harting

|Mar 11, 2019
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Bas D Koster, Saskia J A M Santegoets, Jorien Harting

Pageof 1

Frequent Collaborators

3 joint publications

Bas D Koster

3 joint publications

Tanja D de Gruijl

2 joint publications

Saskia J A M Santegoets

2 joint publications

Erik Hooijberg